BioXcel Therapeutics signs asset sale agreement with Teva
BioXcel Therapeutics entered into an asset sale agreement with Teva Pharmaceuticals.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BTAI enters asset sale agreement with Teva Pharmaceuticals
BioXcel Therapeutics (BTAI) has entered into an asset sale agreement with Teva Pharmaceuticals.